2m 2m 2m 2m 2m 2m 2m
CARIBOU BIO (CRBU)
NASDAQ
$2.04-$0.28 (-12.28%)
Price as of Jun 03, 2026 7:58 PM EDT- $234.1MMarket Cap
- 120.95%1-Year Change
- BiotechnologyIndustry
CARIBOU BIO (CRBU)
$2.04-$0.28 (-12.28%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 2.5M -75.12% | 10.0M -71.01% | 34.5M +148.91% | 13.9M +44.31% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 2.5M -75.12% | 10.0M -71.01% | 34.5M +148.91% | 13.9M +44.31% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -109.4M -15.92% | -130.2M +16.13% | -112.1M +36.29% | -82.2M +57.36% | |
Depreciation and Amortization Expense | 3.6M -7.18% | 3.9M +11.40% | 3.5M +117.32% | 1.6M +64.84% | |
Total Operating Expenses | 159.5M -9.69% | 176.6M +17.32% | 150.5M +25.19% | 120.3M +57.03% | |
Operating Profit | -148.3M -10.97% | -166.6M +43.56% | -116.1M +9.08% | -106.4M +58.85% | |
Interest Income | 8.8M -42.49% | 15.3M -0.83% | 15.5M +225.67% | 4.8M +3,110.81% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 8.8M -42.49% | 15.3M -0.83% | 15.5M +225.67% | 4.8M +3,294.29% | |
Total Nonoperating Income and Expense | -331,000 -101.89% | 17.5M +23.41% | 14.2M +101.22% | 7.0M +1,769.50% | |
Income before Taxes | -148.7M -0.29% | -149.1M +46.37% | -101.9M +2.54% | -99.4M +49.17% | |
Income Taxes | -550,000 +6,011.11% | -9,000 -104.66% | 193,000 +175.71% | 70,000 -78.19% | |
Extraordinary Items | 12.2M N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -148.1M -0.66% | -149.1M +46.08% | -102.1M +2.66% | -99.4M +48.56% | |
Net Income from Continuing Operations Applicable to Common | -148.7M -0.29% | -149.1M +46.37% | -101.9M +2.54% | -99.4M +49.17% | |
Basic EPS and Net Income | -1.59 -3.64% | -1.65 +19.57% | -1.38 -15.85% | -1.64 -22.27% | |
Diluted EPS and Net Income | -1.59 -3.64% | -1.65 +19.57% | -1.38 -15.85% | -1.64 -22.27% | |
Basic Weighted Average Shares | 93.4M +3.40% | 90.3M +22.37% | 73.8M +21.39% | 60.8M +92.02% | |
Diluted Weighted Average Shares | 93.4M +3.40% | 90.3M +22.37% | 73.8M +21.39% | 60.8M +92.02% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 12.4M -24.14% | 16.3M -68.15% | 51.2M -12.30% | 58.3M -75.73% | |
Short-Term Investments | 127.0M -34.29% | 193.2M -30.40% | 277.7M +46.66% | 189.3M +39.81% | |
Cash and Cash Equivalents and Short-Term Investments | 139.3M -33.50% | 209.5M -36.28% | 328.8M +32.77% | 247.7M -34.10% | |
Total Current Assets | 145.2M -33.80% | 219.4M -35.26% | 338.8M +30.20% | 260.2M -33.47% | |
Accumulated Depreciation | 13.5M +4.98% | 12.9M +40.91% | 9.1M +61.87% | 5.6M +38.56% | |
Property and Plant and Equipment and Net | 6.8M -64.94% | 19.3M +5.53% | 18.3M +71.10% | 10.7M +118.50% | |
Total Long-Term Assets | 2.2M -60.15% | 5.5M +248.11% | 1.6M +3.12% | 1.5M +57.74% | |
Total Assets | 175.4M -44.03% | 313.3M -27.51% | 432.2M +15.64% | 373.8M -15.51% | |
Income Taxes Payable | 0 -100.00% | 548,000 -1.62% | 557,000 +46.19% | 381,000 -19.96% | |
Total Short-Term Debt | N/A N/A | 18,000 -95.23% | 377,000 +26.09% | 299,000 +15.44% | |
Total Current Liabilities | 25.4M -17.09% | 30.7M +8.30% | 28.3M +0.62% | 28.1M +8.90% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 26.0M -11.70% | 29.5M -11.02% | 33.1M -23.85% | 43.5M +73.42% | |
Total Liabilities | 53.2M -11.88% | 60.4M -5.40% | 63.8M -12.46% | 72.9M +33.67% | |
Retained Earnings | -596.5M +33.03% | -448.4M +49.82% | -299.3M +51.76% | -197.2M +101.66% | |
Total Stockholders Equity | 122.2M -51.70% | 253.0M -31.34% | 368.4M +22.44% | 300.9M -22.42% | |
Total Shares Outstanding | 95.1M +2.99% | 92.4M +4.44% | 88.4M +44.93% | 61.0M +1.27% | |
Cash Flow | |||||
Cash from Operating Activities | -111.0M -19.69% | -138.2M +48.14% | -93.3M +2.56% | -91.0M +179.73% | |
Capital Expenditures | 1.4M -72.15% | 4.9M -57.98% | 11.6M +79.93% | 6.5M +204.29% | |
Cash from Investing Activities | 102.2M +18.05% | 86.6M +227.02% | -68.2M -26.88% | -93.2M -47.14% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 4.8M -71.17% | 16.7M -89.16% | 154.3M +7,133.85% | 2.1M -99.51% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -5,964.78% +257.78% | -1,667.16% +395.25% | -336.63% -56.18% | -768.17% N/A | |
Return on Assets | -60.62% +51.56% | -40.00% +57.93% | -25.33% +3.96% | -24.36% N/A | |
Return on Equity | -78.97% +64.55% | -47.99% +57.35% | -30.50% +5.64% | -28.87% N/A | |
Revenue Growth | -75.12% +5.78% | -71.01% -147.69% | 148.91% +236.06% | 44.31% N/A | |
Current Ratio | 5.71 -20.16% | 7.16 -40.22% | 11.97 +29.40% | 9.25 N/A | |
Cash Ratio | 0.49 -8.52% | 0.53 -70.59% | 1.81 -12.84% | 2.07 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow